Loading organizations...
Loading organizations...
Develops small molecules for anxiety and neuropsychiatric disorders.
Synendos Therapeutics has raised $21.8M across 1 funding round.
Synendos Therapeutics has raised $21.8M in total across 1 funding round.
Synendos Therapeutics has raised $21.8M in total across 1 funding round.
Synendos Therapeutics's investors include Peter Neubeck, Søren Lemonius, Bettina Ernst, Essential Investments, Fabian Mohr, Lichtsteiner Foundation, Schroder Adveq, Zürcher Kantonalbank.
Synendos Therapeutics has raised $21.8M across 1 funding round. Most recently, it raised $21.8M Series A in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 12, 2020 | $21.8M Series A | Peter Neubeck, Søren Lemonius | Bettina Ernst, Essential Investments, Fabian Mohr, Lichtsteiner Foundation, Schroder Adveq, Zürcher Kantonalbank |